id
stringlengths 1
5
| question_id
stringlengths 1
5
| document_id
stringlengths 5
7
| question
stringlengths 55
970
| type
stringclasses 1
value | choices
list | context
stringlengths 0
971
| answer
sequence |
---|---|---|---|---|---|---|---|
200 | 366 | 3580134 | Compared to Placebo what was the result of Budesonide/formoterol pMDI 320/9 μg on Awakening-free nights percentage improvement? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6]. | [
"significantly increased"
] |
201 | 338 | 3580134 | Compared to Placebo what was the result of Budesonide/formoterol pMDI 160/9 μg on Pre-dose inspiratory capacity? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6]. | [
"no significant difference"
] |
202 | 360 | 3580134 | Compared to Placebo what was the result of Budesonide/formoterol pMDI 160/9 μg on Overall use of daily rescue medication improvement? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6]. | [
"significantly increased"
] |
203 | 420 | 1784771 | Compared to Prostaglandin gel what was the result of Prostaglandin gel plus hygroscopic cervical dilators on Infection? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The combined therapy group had a higher infection rate than the prostaglandin-only group (59% vs. 12%, P = 0.003). | [
"significantly increased"
] |
204 | 457 | 3446002 | Compared to control group what was the result of single dose of 50 mg/kg clofibrate on Total serum bilirubin level? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | On serial daily examination during phototherapy and up to 2 days after that no problems or side effects were observed. Also for a period of two months no complication was detected. | [
"significantly decreased"
] |
205 | 415 | 2575601 | Compared to Pentobarbital what was the result of Thiopental on Sepsis related Organ-Failure Assessment (SOFA) baseline scores? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | There were no differences between groups with respect to the incidence of infections, Sepsis related Organ-Failure Assessment (SOFA) scores before initiation of treatment, | [
"no significant difference"
] |
206 | 242 | 3090298 | Compared to Thin-flap laser in situ keratomileusis (LASIK) what was the result of Photo-refractive keratectomy (PRK) on Higher-order aberrations at 6 months? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | There were no significant differences between groups in any HOAs throughout the study (P ≥ 0.101), with all P values at 6 months ≥0.63. | [
"no significant difference"
] |
207 | 459 | 1913177 | Compared to prosthetic repair with e-PTFE patch (PR) what was the result of components separation technique (CST) on Wound complications? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Wound complications were found in 10 of 19 patients after CST and 13 of 18 patients after PR. | [
"no significant difference"
] |
208 | 280 | 2361806 | Compared to Etoposide with 5-fluorouracil plus leucovorin (ELF) what was the result of Irinotecan with high-dose 5-fluorouracil plus leucovorin (ILF) on Clinical response rates at 14 weeks? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | For ILF and ELF, respectively, median progression-free survival was 4.5 vs 2.3 months, time to treatment failure was 3.6 vs 2.2 months (P=0.4542), and overall survival was 10.8 vs 8.3 months (P=0.2818). | [
"no significant difference"
] |
209 | 236 | 3090298 | Compared to Pre-surgery baseline what was the result of Thin-flap laser in situ keratomileusis (LASIK) on Contrast sensitivity? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | There were no significant differences between groups in any HOAs throughout the study (P ≥ 0.101), with all P values at 6 months ≥0.63. | [
"no significant difference"
] |
210 | 356 | 3580134 | Compared to Placebo what was the result of Budesonide/formoterol pMDI 160/9 μg on Cough score improvement? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6]. | [
"significantly increased"
] |
211 | 451 | 2720945 | Compared to placebo what was the result of cineole on Quality of life? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The difference between the two treatment groups was neither clinically relevant nor statistically significant. Safety examinations of the global assessment showed no difference between the two treatment groups. | [
"significantly increased"
] |
212 | 465 | 3387601 | Compared to intravenous immunoglobulin (IVIG) what was the result of plasma exchange (PE) on Pediatric Intensive Care Unit (PICU) stay? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Examining the treatment groups separately, the significant negative correlation remained for the PE group (p-value = 0.037) and not for the IVIG group (p-value 0.132) | [
"no significant difference"
] |
213 | 337 | 3580134 | Compared to Formoterol DPI 9 μg what was the result of Budesonide/formoterol pMDI 320/9 μg on Pre-dose inspiratory capacity? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6]. | [
"no significant difference"
] |
214 | 318 | 3580134 | Compared to Placebo what was the result of Budesonide/formoterol pMDI 160/9 μg on Peak expiratory flow in the morning and evening ? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6]. | [
"significantly increased"
] |
215 | 475 | 2447617 | Compared to placebo what was the result of progesterone on The modified Functional Independence Measure scores? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The percentage of favorable outcome was 58% for the patients who were given progesterone and was 42% in the placebo group (P = 0.048). Forty-one percent of patients who were given progesterone and 57% of the placebo group exhibited an unfavorable outcome (P = 0.048). | [
"significantly increased"
] |
216 | 219 | 1475568 | Compared to Standard information about self-care what was the result of Follow-up and thorough education on self-care on Baseline systolic dysfunction? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The control group did have statistically significantly higher baseline MLHF scores representing worse symptoms at baseline. | [
"no significant difference"
] |
217 | 340 | 3580134 | Compared to Formoterol DPI 9 μg what was the result of Budesonide/formoterol pMDI 160/9 μg on 1-hour post-dose inspiratory capacity mean improvements from baseline to the average over the randomized treatment period ? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6]. | [
"significantly increased"
] |
218 | 243 | 2922723 | Compared to Usual airway clearance techniques what was the result of High frequency chest wall oscillation on Sputum expectoration during a single session? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Patients scored the efficacy of their usual ACT significantly higher than for HFCWO (mean difference 14 mm; p=0.002). | [
"significantly decreased"
] |
219 | 270 | 2691927 | Compared to Conventional open approach what was the result of Laparoscopic surgery on Ulcer mean diameter? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Differences regarding postoperative dosage of opiates and the visual analog scale (VAS) for pain scoring system were in favor of the laparoscopic procedure. | [
"no significant difference"
] |
220 | 408 | 2575601 | Compared to Pentobarbital what was the result of Thiopental on Refractory intracranial pressure? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | There were no differences between groups with respect to the incidence of infections, Sepsis related Organ-Failure Assessment (SOFA) scores before initiation of treatment, | [
"significantly decreased"
] |
221 | 327 | 3580134 | Compared to Placebo what was the result of Budesonide/formoterol pMDI 320/9 μg on Baseline-adjusted average 12-hour FEV1 at end of treatment? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6]. | [
"significantly increased"
] |
222 | 357 | 3580134 | Compared to Placebo what was the result of Budesonide/formoterol pMDI 160/9 μg on Sputum score improvement? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6]. | [
"significantly increased"
] |
223 | 230 | 3090298 | Compared to Thin-flap laser in situ keratomileusis (LASIK) what was the result of Photo-refractive keratectomy (PRK) on Uncorrected distance visual acuity at 3 months? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | There were no significant differences between groups in any HOAs throughout the study (P ≥ 0.101), with all P values at 6 months ≥0.63. | [
"no significant difference"
] |
224 | 436 | 1201146 | Compared to vehicle control solution (carrier with no diclofenac) what was the result of topical diclofenac solution (Pennsaid®) on Pain on walking? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | There was a significantly greater improvement in score with topical diclofenac compared to vehicle control (Table 2) for pain on walking (-1.2 vs. -0.8; p = 0.014). | [
"significantly decreased"
] |
225 | 396 | 2690844 | Compared to Midline incision what was the result of Transverse incision on Average patient's lenght? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Postoperative complications (Table 4) were seen in 16 out of 75 patients (21%) from the midline incision group and in 15% from the transverse incision group (11 patients) (P = 0.30). | [
"no significant difference"
] |
226 | 223 | 1475568 | Compared to Standard information about self-care what was the result of Follow-up and thorough education on self-care on Baseline angiotensin II receptor blockers (ARBs) intake? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The control group did have statistically significantly higher baseline MLHF scores representing worse symptoms at baseline. | [
"no significant difference"
] |
227 | 253 | 1831737 | Compared to Communities that received standard Government services what was the result of Communities that received additional education and preventive measures on HIV-1 prevalence? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | T. vaginalis infection, secondary school education, and spatial mobility were more common in the control communities, whilst history of genital discharge and uptake of STI treatment and VCT services offered in the survey were low overall but more frequent in the intervention communities (Table 1). However, the differences in each case were small and were unlikely to be clinically meaningful. | [
"significantly increased"
] |
228 | 351 | 3580134 | Compared to Placebo what was the result of Budesonide/formoterol pMDI 160/9 μg on Improvements in St. George's Respiratory Questionnaire overall score? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6]. | [
"significantly increased"
] |
229 | 222 | 1475568 | Compared to Standard information about self-care what was the result of Follow-up and thorough education on self-care on Baseline digoxin intake? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The control group did have statistically significantly higher baseline MLHF scores representing worse symptoms at baseline. | [
"no significant difference"
] |
230 | 329 | 3580134 | Compared to Placebo what was the result of Budesonide/formoterol pMDI 160/9 μg on Baseline-adjusted average 12-hour FEV1 on the day of randomization? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6]. | [
"significantly increased"
] |
231 | 388 | 2690844 | Compared to Midline incision what was the result of Transverse incision on Incisional hernia apparition at follow-up? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Postoperative complications (Table 4) were seen in 16 out of 75 patients (21%) from the midline incision group and in 15% from the transverse incision group (11 patients) (P = 0.30). | [
"significantly decreased"
] |
232 | 444 | 1468428 | Compared to no enema what was the result of 1 litre saline enema on Median labour time? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | We found no significant differences in puerperal or neonatal infection rates (Puerperal infection: 41/190 [22%] with enema v 26/182 [14%] without enema; RR 0.66 CI 95%: 0.43 to 1.03; neonatal infection 38/191 [20%] with enema v 40/179 [22%] without enema; RR 1.12, 95% CI 95% 0.76 to 1.66) | [
"no significant difference"
] |
233 | 462 | 1876597 | Compared to artemether-lumefantrine what was the result of dihydroartemisinin-piperaquine on the risk of recurrent parasitemia due to possible recrudescence? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Overall, there was no difference in the proportion of study participants who experienced any adverse event of moderate or greater severity between the DP (46%) and AL (42%) treatment groups (p = 0.47). | [
"significantly decreased"
] |
234 | 394 | 2690844 | Compared to Midline incision what was the result of Transverse incision on Analgesics use? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Postoperative complications (Table 4) were seen in 16 out of 75 patients (21%) from the midline incision group and in 15% from the transverse incision group (11 patients) (P = 0.30). | [
"no significant difference"
] |
235 | 311 | 3580134 | Compared to Placebo what was the result of Budesonide/formoterol pMDI 160/9 μg on Time to discontinuation? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6]. | [
"significantly increased"
] |
236 | 332 | 3580134 | Compared to Formoterol DPI 9 μg what was the result of Budesonide/formoterol pMDI 320/9 μg on Baseline-adjusted average 12-hour FEV1 on the day of randomization? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6]. | [
"significantly increased"
] |
237 | 221 | 1475568 | Compared to Standard information about self-care what was the result of Follow-up and thorough education on self-care on Baseline angiotensin-converting enzyme (ACE) inhibitors intake? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The control group did have statistically significantly higher baseline MLHF scores representing worse symptoms at baseline. | [
"no significant difference"
] |
238 | 235 | 3090298 | Compared to Thin-flap laser in situ keratomileusis (LASIK) what was the result of Photo-refractive keratectomy (PRK) on Contrast sensitivity? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | There were no significant differences between groups in any HOAs throughout the study (P ≥ 0.101), with all P values at 6 months ≥0.63. | [
"no significant difference"
] |
239 | 352 | 3580134 | Compared to Placebo what was the result of Budesonide/formoterol pMDI 320/9 μg on Improvements in St. George's Respiratory Questionnaire overall score? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6]. | [
"significantly increased"
] |
240 | 418 | 1784771 | Compared to Prostaglandin gel what was the result of Prostaglandin gel plus hygroscopic cervical dilators on Baseline demographic differences? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The combined therapy group had a higher infection rate than the prostaglandin-only group (59% vs. 12%, P = 0.003). | [
"no significant difference"
] |
241 | 453 | 2720945 | Compared to placebo what was the result of cineole on Trouble in breathing, dyspnea in the morning and dyspnea at rest? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The difference between the two treatment groups was neither clinically relevant nor statistically significant. Safety examinations of the global assessment showed no difference between the two treatment groups. | [
"significantly decreased"
] |
242 | 321 | 3580134 | Compared to Formoterol DPI 9 μg what was the result of Budesonide/formoterol pMDI 320/9 μg on Peak expiratory flow in the morning and evening ? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6]. | [
"significantly increased"
] |
243 | 262 | 1831737 | Compared to Baseline communities that received standard Government services what was the result of Baseline communities that received additional education and preventive measures on High-risk sexual behaviour? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | T. vaginalis infection, secondary school education, and spatial mobility were more common in the control communities, whilst history of genital discharge and uptake of STI treatment and VCT services offered in the survey were low overall but more frequent in the intervention communities (Table 1). However, the differences in each case were small and were unlikely to be clinically meaningful. | [
"no significant difference"
] |
244 | 378 | 3580134 | Compared to Formoterol DPI 9 μg what was the result of Budesonide/formoterol pMDI 320/9 μg on 24-hour urinary cortisol at end of treatment? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6]. | [
"significantly decreased"
] |
245 | 349 | 3580134 | Compared to Formoterol DPI 9 μg what was the result of Budesonide/formoterol pMDI 160/9 μg on Amount of exacerbations per patient-treatment year? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6]. | [
"significantly decreased"
] |
246 | 312 | 3580134 | Compared to Placebo what was the result of Budesonide/formoterol pMDI 160/9 μg on Pre-dose FEV1 improvement? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6]. | [
"significantly increased"
] |
247 | 372 | 3580134 | Compared to Formoterol DPI 9 μg what was the result of Budesonide/formoterol pMDI 320/9 μg on Overall use of daily rescue medication improvement? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6]. | [
"significantly increased"
] |
248 | 267 | 2691927 | Compared to Conventional open approach what was the result of Laparoscopic surgery on Postoperative complications? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Differences regarding postoperative dosage of opiates and the visual analog scale (VAS) for pain scoring system were in favor of the laparoscopic procedure. | [
"no significant difference"
] |
249 | 249 | 2922723 | Compared to Usual airway clearance techniques what was the result of High frequency chest wall oscillation on Visual analogue scale scores for urinary leakage? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Patients scored the efficacy of their usual ACT significantly higher than for HFCWO (mean difference 14 mm; p=0.002). | [
"no significant difference"
] |
250 | 272 | 2691927 | Compared to Conventional open approach what was the result of Laparoscopic surgery on Median loss of blood? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Differences regarding postoperative dosage of opiates and the visual analog scale (VAS) for pain scoring system were in favor of the laparoscopic procedure. | [
"no significant difference"
] |
251 | 404 | 2690844 | Compared to Midline incision what was the result of Transverse incision on Hospital stay? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Postoperative complications (Table 4) were seen in 16 out of 75 patients (21%) from the midline incision group and in 15% from the transverse incision group (11 patients) (P = 0.30). | [
"no significant difference"
] |
252 | 320 | 3580134 | Compared to Formoterol DPI 9 μg what was the result of Budesonide/formoterol pMDI 160/9 μg on Peak expiratory flow in the morning and evening ? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6]. | [
"significantly increased"
] |
253 | 469 | 2430614 | Compared to artemether-lumefantrine (AL) and and Artesunate+chlorproguanil-dapsone (AS+CD) what was the result of Artesunate+amodiaquine (AS+AQ) on the parasitological and clinical failure rate at day 28 post treatment? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | the parasitological and clinical failure rate at day 28 post treatment (PCF28) was lower in the AS+AQ group compared to the AL or AS+CD groups (corrected for re-infections: 6.6% vs 13.8% and 13.8% respectively, p = 0.08; uncorrected: 14.6% vs 27.6% and 28.1% respectively, p = 0.005). | [
"no significant difference"
] |
254 | 611 | 5577662 | Compared to dose of 0.25 mg, 0.40 mg, or 0.60 mg (1:1:1 ratio) and then allocated placebo (4:1 ratio) what was the result of receive a dose of 0.25 mg (1:1:1 ratio) and then allocated to active treatment (CCH) on percentage changes in area? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | percentage changes in area were significantly greater with CCH 0.40 mg (−80.1%, P = 0.0002) and CCH 0.60 mg (−78.2%, P = 0.0003), but not CCH 0.25 mg (−58.3%, P = 0.079), versus placebo (−42.2%) at post-treatment Week 8. | [
"no significant difference"
] |
255 | 578 | 4577567 | Compared to free stride frequency what was the result of stride frequency manipulation on internal work? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | nversely, a decreased stride frequency (4.44%; p<0.0001) and internal work (7.09%; p<0.05) were found. | [
"significantly decreased"
] |
256 | 619 | 4139977 | Compared to similar placebo, twice daily after a meal for 14 consecutive days what was the result of receive a probiotic compound containing seven bacteria species including Lactobacillus strains, Bifidobacterium strains and Streptococcus thermophiles on Improvement in bowel habit? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | mprovement in bowel habit was observed in 33.3% of the probiotic and 36.5% of the placebo group (P = 0.910). | [
"no significant difference"
] |
257 | 608 | 5577662 | Compared to dose of 0.25 mg, 0.40 mg, or 0.60 mg (1:1:1 ratio) and then allocated placebo (4:1 ratio) what was the result of receive a dose of 0.40 mg, or 0.60 mg (1:1:1 ratio) and then allocated to active treatment (CCH) on percentage changes in area? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | percentage changes in area were significantly greater with CCH 0.40 mg (−80.1%, P = 0.0002) and CCH 0.60 mg (−78.2%, P = 0.0003), but not CCH 0.25 mg (−58.3%, P = 0.079), versus placebo (−42.2%) at post-treatment Week 8. | [
"significantly increased"
] |
258 | 595 | 4819709 | Compared to surgery what was the result of Ultrasound‐guided foam sclerotherapy on Full return to normal work/employment? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Participants randomized to UGFS recalled being able to carry out 13 of the 15 behaviours significantly more quickly than those randomized to surgery (Table
2
). | [
"significantly increased"
] |
259 | 593 | 4819709 | Compared to surgery what was the result of Ultrasound‐guided foam sclerotherapy on Wearing clothes that show the legs? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Participants randomized to UGFS recalled being able to carry out 13 of the 15 behaviours significantly more quickly than those randomized to surgery (Table
2
). | [
"no significant difference"
] |
260 | 551 | 125315 | Compared to received only standard therapy for sepsis what was the result of received standard therapy for sepsis and physiological-dose steroid therapy for 10 days; on The median stay in hospital? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The median stay in hospital was 14 days (95% CI 11.09–20.08) in the steroid therapy group and 13 days (95% CI 10.13–16.37) in the standard therapy group (P = 0.406). | [
"no significant difference"
] |
261 | 556 | 4785315 | Compared to standard maternity care what was the result of additional lay support (in this instance Pregnancy Outreach Workers, POWs) on Postnatal depression (Edinburgh Postnatal Depression Scale17 EPDS)? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | no significant differences were seen in the mean EPDS (mean difference (MD) −0.59 (95% CI −1.24 to 0.06)) for all the women recruited | [
"no significant difference"
] |
262 | 519 | 1261533 | Compared to Mefloquine-artesunate what was the result of Artemether-lumefantrine on Decrease in haematocrit level at day 7? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The mean (SD) decrease in haematocrit value at day seven from baseline was greater in the group receiving MAS3 than in the ALN group: 9.3% (SD | [
"significantly decreased"
] |
263 | 620 | 4139977 | Compared to similar placebo, twice daily after a meal for 14 consecutive days what was the result of receive a probiotic compound containing seven bacteria species including Lactobacillus strains, Bifidobacterium strains and Streptococcus thermophiles on quality-of-life ? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | mprovement in bowel habit was observed in 33.3% of the probiotic and 36.5% of the placebo group (P = 0.910). | [
"no significant difference"
] |
264 | 583 | 4819709 | Compared to surgery what was the result of Ultrasound‐guided foam sclerotherapy on Bending the legs without discomfort? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Participants randomized to UGFS recalled being able to carry out 13 of the 15 behaviours significantly more quickly than those randomized to surgery (Table
2
). | [
"significantly increased"
] |
265 | 599 | 4819709 | Compared to Ultrasound‐guided foam sclerotherapy what was the result of Endovenous laser ablation on walking short distances without discomfort, walking long distances, looking after children, full return to normal work/employment? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Participants randomized to UGFS recalled being able to carry out 13 of the 15 behaviours significantly more quickly than those randomized to surgery (Table
2
). | [
"significantly decreased"
] |
266 | 582 | 3800940 | Compared to Godugdha sodhit Langali moola with honey for external application what was the result of Gomutra sodhit Langali moola with honey for external application on Indralupta is a unique, idiopathic, non-cictricial, non-inflammatory alopecia, presents as discoid areas of hair loss.? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | It was observed that after 60 days of treatment with Gomutrashodhit Langlimool in Group A there was reduction in Hair fall which is statistically highly significant (P<0.001) and highly significant improvement was observed in reducing dandruff.(p<0.001). Where as in Group B Godugdashodhit Langlimool application reduced the hair fall to statistically significant level (p<0.01) and statistically significant in reducing the dandruff in patient with Indralupta (P<0.01). | [
"significantly decreased"
] |
267 | 560 | 2888205 | Compared to fibromyalgia (FM) education control (FME) group - received information and support what was the result of lifestyle physical activity (LPA) - 30 minutes of self-selected moderate-intensity LPA, five to seven days per week on pain? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | At post-testing, compared to the FME group, the LPA group reported significant reductions in the FIQ score (P = .032; Cohen's d = .53) and in pain (P = .006; Cohen's d = .67). | [
"significantly decreased"
] |
268 | 485 | 2806484 | Compared to Facility-based HIV-care strategy what was the result of Home-based HIV-care strategy on Virological failure? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Rates of detection of plasma viral loads of more than 500 copies per mL after a 6-month visit were much the same in both groups. | [
"no significant difference"
] |
269 | 561 | 2888205 | Compared to fibromyalgia (FM) education control (FME) group - received information and support what was the result of lifestyle physical activity (LPA) - 30 minutes of self-selected moderate-intensity LPA, five to seven days per week on six-minute walk test? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | At post-testing, compared to the FME group, the LPA group reported significant reductions in the FIQ score (P = .032; Cohen's d = .53) and in pain (P = .006; Cohen's d = .67). | [
"no significant difference"
] |
270 | 534 | 3198285 | Compared to high-fiber moderate-GI diet (HF) (target glycemic index GI ~60) what was the result of low–glycemic index diet (target glycemic index [GI] ~50) on low–glycemic index? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The LGI group achieved a modestly lower GI than the HF group (mean ± SEM 47 ± 1 vs. 53 ± 1; P < 0.001). | [
"significantly decreased"
] |
271 | 589 | 4819709 | Compared to surgery what was the result of Ultrasound‐guided foam sclerotherapy on Having a bath or shower? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Participants randomized to UGFS recalled being able to carry out 13 of the 15 behaviours significantly more quickly than those randomized to surgery (Table
2
). | [
"no significant difference"
] |
272 | 601 | 2891743 | Compared to glucose 5% solution what was the result of glycine 1.5% solution as irrigating fluid on transurethral resection (TUR) syndrome? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | TUR syndrome 17* 0 0 | [
"significantly increased"
] |
273 | 510 | 1964758 | Compared to BioModular® shoulder prosthesis what was the result of Initial Nottingham TSR design prosthesis on 8-year survivorship in patients with osteoarthritis? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The initial Nottingham TSR prostheses showed higher eight year survivorship than BioModular® prostheses in patients with OA (p < 0.01). Survivorship of the BioModular® prosthesis in patients with primary osteoarthritis was 70.9% and 64.3% at five and eight years respectively and for the initial Nottingham TSR these values were 84.5% and 80.4% | [
"significantly increased"
] |
274 | 602 | 2891743 | Compared to normal saline 0.9% solution what was the result of glycine 1.5% solution as irrigating fluid on transurethral resection (TUR) syndrome? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | TUR syndrome 17* 0 0 | [
"significantly increased"
] |
275 | 512 | 2829413 | Compared to Atorvastatin what was the result of Rosuvastatin on Levels of LDL cholesterol after 6 weeks of treatment? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | After 6 weeks of treatment, greater reductions in total cholesterol (- 35.94 ± 11.38 vs. - 30.07 ± 10.46%, p < 0.001), LDL-C (48.04 ± 14.45 vs. 39.52 ± 14.42%, p < 0.001), non-high-density lipoprotein cholesterol (- 42.93 ± 13.15 vs. - 35.52 ± 11.76%, p < 0.001), and apolipoprotein-B (- 38.7 ± 18.85 vs. - 32.57 ± 17.56%, p = 0.002) levels were observed in the rosuvastatin group as compared to the atorvastatin group. | [
"significantly decreased"
] |
276 | 610 | 5577662 | Compared to dose of 0.25 mg, 0.40 mg, or 0.60 mg (1:1:1 ratio) and then allocated placebo (4:1 ratio) what was the result of receive a dose of 0.40 mg, or 0.60 mg (1:1:1 ratio) and then allocated to active treatment (CCH) on global assessment of improvement? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | percentage changes in area were significantly greater with CCH 0.40 mg (−80.1%, P = 0.0002) and CCH 0.60 mg (−78.2%, P = 0.0003), but not CCH 0.25 mg (−58.3%, P = 0.079), versus placebo (−42.2%) at post-treatment Week 8. | [
"significantly increased"
] |
277 | 522 | 1261533 | Compared to Mefloquine-artesunate what was the result of Artemether-lumefantrine on P. vivax parasitaemia diagnosed during follow up? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The mean (SD) decrease in haematocrit value at day seven from baseline was greater in the group receiving MAS3 than in the ALN group: 9.3% (SD | [
"significantly increased"
] |
278 | 531 | 2364680 | Compared to opening subcutaneous tissues with scalpel what was the result of opening subcutaneous tissues with electrocautery on wound problem? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Fifteen of 380 women (3.9%) developed a wound problem; six had scalpel and nine had
electrosurgical subcutaneous incisions (P = 0.4). | [
"no significant difference"
] |
279 | 491 | 2363351 | Compared to Cisplatin and Cyclophosphamide what was the result of Cisplatin and Cyclophosphamide, plus subcutaneous IFN-γ on Overall survival at 3 years? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Three-year overall survival was 58% and 74% accordingly (n.s., median not yet reached). | [
"no significant difference"
] |
280 | 536 | 3198285 | Compared to high-fiber moderate-GI diet (HF) (target glycemic index GI ~60) what was the result of low–glycemic index diet (target glycemic index [GI] ~50) on Birth weight (kg), Birth weight centile, Small for gestational age, Macrosomia, Infant head circumference, Infant length (cm), Ponderal index (kg/m3), Maternal weight gain (kg), Insulin treatment, Emergency caesarean? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The LGI group achieved a modestly lower GI than the HF group (mean ± SEM 47 ± 1 vs. 53 ± 1; P < 0.001). | [
"no significant difference"
] |
281 | 498 | 2364533 | Compared to Placebo what was the result of Erythromycin on Preterm delivery? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | When the results were examined without regard to study site, erythromycin had little impact on reducing low birth weight (8% vs. 11%, P = 0.4) or preterm delivery (13% vs. 15%, P = 0.7) | [
"no significant difference"
] |
282 | 487 | 2806484 | Compared to Facility-based HIV-care strategy what was the result of Home-based HIV-care strategy on Costs for the health service? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Rates of detection of plasma viral loads of more than 500 copies per mL after a 6-month visit were much the same in both groups. | [
"no significant difference"
] |
283 | 609 | 5577662 | Compared to dose of 0.25 mg, 0.40 mg, or 0.60 mg (1:1:1 ratio) and then allocated placebo (4:1 ratio) what was the result of receive a dose of 0.25 mg, 0.40 mg, or 0.60 mg (1:1:1 ratio) and then allocated to active treatment (CCH) on Mean change in nodular consistency and hardness? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | percentage changes in area were significantly greater with CCH 0.40 mg (−80.1%, P = 0.0002) and CCH 0.60 mg (−78.2%, P = 0.0003), but not CCH 0.25 mg (−58.3%, P = 0.079), versus placebo (−42.2%) at post-treatment Week 8. | [
"significantly increased"
] |
284 | 591 | 4819709 | Compared to surgery what was the result of Ultrasound‐guided foam sclerotherapy on Doing housework? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Participants randomized to UGFS recalled being able to carry out 13 of the 15 behaviours significantly more quickly than those randomized to surgery (Table
2
). | [
"significantly increased"
] |
285 | 539 | 2722000 | Compared to received antibiotics only when infection was suspected or established what was the result of received antibiotics treatment after randomization with intravenous cefotaxime 2 gram q 8 hr for 7 days on rebleeding? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The rebleeding rate in the prophylactic group was significantly lower than that in the on-demand group (21/62, 33.9% vs. 36/58, 62.1%, p=0.004). | [
"significantly decreased"
] |
286 | 543 | 2650992 | Compared to control group what was the result of fibrin glue group (glue sprayed onto the axillary dissection site) on The mean drainage duration? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The mean drainage duration was 3.3 days for the fibrin glue group and 3.8 days for the control group (p=0.067). | [
"no significant difference"
] |
287 | 533 | 3221331 | Compared to set a quit date and received a general health video message sent to their phone every 2 weeks. what was the result of an automated package of video and text messages over 6 months that was tailored to self-selected quit date, role model, and timing of messages. Extra messages were available on demand to beat cravings and address lapses. on did not attempt to quit smoking at all? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | At 6 months all participants were asked how many quit attempts they had made during the study period. In the intervention group 7/73 respondents (9.6%) and in the control group 4/81 (4.9%) (P = .3) stated they did not attempt to quit at all, but the majority of respondents in both groups made multiple quit attempts. | [
"no significant difference"
] |
288 | 314 | 3580134 | Compared to Placebo what was the result of Budesonide/formoterol pMDI 320/9 μg on Pre-dose FEV1 improvement? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6]. | [
"significantly increased"
] |
289 | 333 | 3580134 | Compared to Formoterol DPI 9 μg what was the result of Budesonide/formoterol pMDI 160/9 μg on Baseline-adjusted average 12-hour FEV1 on the day of randomization? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6]. | [
"significantly increased"
] |
290 | 335 | 3580134 | Compared to Formoterol DPI 9 μg what was the result of Budesonide/formoterol pMDI 320/9 μg on Mean FEV1 at 12 hours at end of treatment? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6]. | [
"significantly increased"
] |
291 | 390 | 2690844 | Compared to Midline incision what was the result of Transverse incision on Better cosmetic appearance of the incision as subjectively assessed by surgeons? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Postoperative complications (Table 4) were seen in 16 out of 75 patients (21%) from the midline incision group and in 15% from the transverse incision group (11 patients) (P = 0.30). | [
"significantly increased"
] |
292 | 359 | 3580134 | Compared to Placebo what was the result of Budesonide/formoterol pMDI 160/9 μg on Awakening-free nights percentage improvement? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6]. | [
"significantly increased"
] |
293 | 425 | 1187893 | Compared to No exercise what was the result of Exercise on SF-36 Mental Component Summary scale at 6 weeks? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | In the exercise group, an improvement was seen at 6 weeks in the KOOS subscale quality of life compared to the control group (mean change 4.0 vs. -0.7, p = 0.05). The difference between groups was still persistent at 6 months (p = 0.02). | [
"significantly increased"
] |
294 | 348 | 3580134 | Compared to Placebo what was the result of Budesonide/formoterol pMDI 320/9 μg on Amount of exacerbations per patient-treatment year? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6]. | [
"significantly decreased"
] |
295 | 330 | 3580134 | Compared to Formoterol DPI 9 μg what was the result of Budesonide/formoterol pMDI 320/9 μg on Mean FEV1 at 12 hours on the day of randomization? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6]. | [
"significantly increased"
] |
296 | 331 | 3580134 | Compared to Formoterol DPI 9 μg what was the result of Budesonide/formoterol pMDI 160/9 μg on Mean FEV1 at 12 hours on the day of randomization? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6]. | [
"significantly increased"
] |
297 | 234 | 3090298 | Compared to Thin-flap laser in situ keratomileusis (LASIK) what was the result of Photo-refractive keratectomy (PRK) on 1 line or more of CDVA at 6 months? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | There were no significant differences between groups in any HOAs throughout the study (P ≥ 0.101), with all P values at 6 months ≥0.63. | [
"no significant difference"
] |
298 | 325 | 3580134 | Compared to Placebo what was the result of Budesonide/formoterol pMDI 160/9 μg on Mean FEV1 at 12 hours at end of treatment? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6]. | [
"significantly increased"
] |
299 | 383 | 2721929 | Compared to Bladder training only (BT) what was the result of Bladder training plus tolterodine (Co) on Micturition frequency? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Mean urgency score decreased by 44.8%, 62.2% and 60.2% in the BT, To, and Co groups, respectively, and the improvement was significantly greater in the To and Co groups than in the BT group (p<0.05 for each). | [
"significantly decreased"
] |